Description
Data Sheet
| Description | Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton. |
| Expression host | Baculovirus Insect Cells. |
| Formulation | The Recombinant H3N2 A/New-York/55/04 solution contains 10mM Sodium phosphate, pH 7.2 and 150mM NaCl. |
| Product Description | Reacts strongly with human HIV positive serum. |
| Protein Background | H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. |
| Purity | Greater than 90.0% as determined by SDS-PAGE. |
| Reagent Appearance | Sterile Filtered colorless solution. |
| Stability | H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Do NOT Freeze! |
